Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

635
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
635
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.4K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.4K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.4K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

905
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
905
Glaucoma: Overview01:25

Glaucoma: Overview

1.4K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.4K
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

2.6K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Roadmap for Development of Community Engagement: Early Lessons Learned From the RECOVER Initiative.

Progress in community health partnerships : research, education, and action·2026
Same author

Budd-Chiari Syndrome: Presentation, Management, and Prognosis.

The American journal of gastroenterology·2025
Same author

Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-on-Chronic Liver Failure.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

Journal of hepatology·2025
Same author

Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025
Same author

Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.

Hepatology international·2025

Related Experiment Video

Updated: Feb 19, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.0K

Portal Hypertensive gastropathy.

Paul J Thuluvath1, Hwan Y Yoo

  • 1Division of Gastroenterology and Hepatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

The American Journal of Gastroenterology
|December 21, 2002
PubMed
Summary

Portal hypertensive gastropathy (PHG) is a common endoscopic finding in portal hypertension. Simple grading systems show better agreement for PHG severity, with nonselective beta-blockers recommended for bleeding prophylaxis.

More Related Videos

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.4K
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.5K

Related Experiment Videos

Last Updated: Feb 19, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.0K
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.4K
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.5K

Area of Science:

  • Gastroenterology
  • Hepatology
  • Endoscopy

Background:

  • Portal hypertensive gastropathy (PHG) is an endoscopic finding in patients with portal hypertension, characterized by a mosaic-like pattern of the gastric mucosa.
  • Existing classification systems for PHG severity have limitations, impacting prevalence estimates and clinical management.
  • The pathogenesis of PHG is closely linked to portal hypertension, though not fully elucidated.

Purpose of the Study:

  • To review the current understanding of portal hypertensive gastropathy (PHG).
  • To discuss the limitations of existing PHG classification systems and the potential benefits of simpler grading.
  • To explore the relationship between PHG and GAVE, and current treatment recommendations.

Main Methods:

  • Review of existing literature on portal hypertensive gastropathy (PHG).
  • Analysis of endoscopic findings and classification systems.
  • Discussion of pathogenetic factors and clinical management strategies.

Main Results:

  • Simple grading systems for PHG demonstrate improved inter- and intraobserver agreement compared to complex systems.
  • Variations in reported PHG prevalence are attributed to selection bias, inconsistent criteria, and observer variability.
  • Severe PHG may present with a GAVE-like appearance, but GAVE is a distinct entity.

Conclusions:

  • Simpler classification systems may enhance diagnostic consistency for portal hypertensive gastropathy (PHG).
  • Nonselective beta-blockers are currently the recommended prophylactic treatment for bleeding associated with PHG.
  • Further research into PHG pathogenesis and standardized classification is warranted.